Sequana Medical NV (EBR: SEQUA)
Belgium
· Delayed Price · Currency is EUR
2.600
-0.030 (-1.14%)
Jan 21, 2025, 9:03 AM CET
Sequana Medical NV Revenue
Sequana Medical NV had revenue of 105.50K EUR in the half year ending June 30, 2024, a decrease of -77.28%. This brings the company's revenue in the last twelve months to 433.50K, down -48.54% year-over-year. In the year 2023, Sequana Medical NV had annual revenue of 712.17K, down -22.82%.
Revenue (ttm)
433.50K
Revenue Growth
-48.54%
P/S Ratio
174.73
Revenue / Employee
6.99K
Employees
62
Market Cap
111.09M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 712.17K | -210.51K | -22.82% |
Dec 31, 2022 | 922.69K | 552.19K | 149.04% |
Dec 31, 2021 | 370.50K | -592.78K | -61.54% |
Dec 31, 2020 | 963.28K | -7.36K | -0.76% |
Dec 31, 2019 | 970.64K | -58.54K | -5.69% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
argenx SE | 1.71B |
UCB SA | 5.45B |
Fagron NV | 820.76M |
Nyxoah | 5.08M |
Ion Beam Applications | 465.75M |
Onward Medical | -188.00K |
Hyloris Pharmaceuticals | 6.94M |
Biocartis Group NV | 60.82M |